Seer Healthcare

Seer Healthcare, founded in 2017 and headquartered in Melbourne, Australia, specializes in home-based epilepsy diagnostics through its proprietary cloud, web, and AI technologies.

Reviewed by 7wData
Share Email

On this page

Profile

Develops AI-powered home monitoring systems for epilepsy diagnosis.

Seer Healthcare, founded in 2017 and headquartered in Melbourne, Australia, specializes in home-based epilepsy diagnostics through its proprietary cloud, web, and AI technologies. The company's flagship product, Seer Home, enables long-term video electroencephalography (EEG) monitoring outside hospital settings, targeting the 50 million global epilepsy patients. In April 2025, Seer Medical secured a strategic investment from Cadwell Industries, a neurodiagnostic equipment manufacturer, alongside Breakthrough Victoria and TrialCap, to integrate its home EEG tech with Cadwell's hospital-based systems.

This partnership expanded Cadwell's product line and granted access to Seer's Melbourne team. While financials are undisclosed, the deal underscores Seer's pivot from standalone diagnostics to embedded solutions within larger medical device ecosystems. The company now faces execution risks as it scales its technology across Cadwell's distribution channels while maintaining its AI-driven diagnostic accuracy.

Track Seer Healthcare and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Neurology clinics offering outpatient care
  • Hospitals seeking decentralized diagnostic options
  • Clinical research organizations running epilepsy trials
  • Telemedicine providers expanding remote neurology services

Strengths and what to watch

Strengths

  • Proprietary home EEG technology validated for epilepsy detection without hospitalization
  • Strategic partnership with Cadwell provides manufacturing and distribution scale
  • AI algorithms reduce manual review time for neurologists interpreting EEG data

Watch for

  • Integration risks with Cadwell's legacy hospital-focused systems
  • Regulatory scrutiny of AI diagnostic accuracy in home settings
  • Dependence on Cadwell for commercial growth post-acquisition

Key Information

Founded
2017
Headquarters
Melbourne, Australia

Frequently Asked Questions

What does Seer Healthcare do?

Seer Healthcare develops AI-powered home monitoring systems for epilepsy diagnosis. Their Seer Home product enables long-term video EEG monitoring outside hospitals, serving 50 million global epilepsy patients. Founded in 2017, the Melbourne-based company combines cloud, web and AI technologies for outpatient neurological diagnostics.

How does Seer's home EEG monitoring work?

Seer's system uses proprietary AI to analyze EEG data from home-based tests, eliminating hospital visits. Their technology captures brain activity through wearable sensors while video records seizures. AI algorithms then process this data to help neurologists diagnose epilepsy patterns remotely with reduced manual review time.

Why did Cadwell invest in Seer Healthcare?

Cadwell Industries made a strategic 2025 investment to integrate Seer's home EEG tech with their hospital systems. This expands Cadwell's product line while giving Seer access to manufacturing scale and distribution channels. The partnership combines Seer's AI diagnostics with Cadwell's neurodiagnostic equipment expertise.

Who uses Seer Healthcare's epilepsy monitoring?

Seer serves neurology clinics offering outpatient care, hospitals needing decentralized options, clinical research organizations running epilepsy trials, and telemedicine providers expanding remote neurology services. Their home EEG technology meets demand for diagnostic solutions beyond traditional hospital settings.

Is Seer's AI accurate for epilepsy diagnosis?

Seer's AI algorithms are validated for epilepsy detection, reducing neurologists' manual review time. However, as the technology scales through Cadwell's channels, maintaining diagnostic accuracy in diverse home environments remains a key challenge subject to ongoing regulatory scrutiny.

What are the risks of Seer's Cadwell partnership?

Key risks include integrating Seer's home tech with Cadwell's hospital systems, regulatory hurdles for AI diagnostics, and dependence on Cadwell for commercial growth. Success requires balancing rapid scaling with maintained accuracy as the technologies merge across different care settings.

Sources

  1. www.prnewswire.com — Cadwell's strategic investment and Seer's home EEG technology
  2. www.seerhealthcare.com — Company's product focus and value proposition
  3. www.sec.gov — Corporate filings context (though outdated)
  4. www.reuters.com — Background on industry reporting